- DArRT-PCR tests involves testing dry swabs from patients: Scientists
- Dry Nasal samples can be sent to testing labs easily for new tests: Expert
- Coronavirus can be contained by testing more frequently: Experts
Hyderabad: The CSIR-Centre for Cellular and Molecular Biology (CCMB) and the Apollo Hospitals Enterprise Limited have announced a collaboration for joint manufacturing and commercialisation of an innovative dry swab test, Direct Amplification rapid RT-PCR (DArRT-PCR) – for SARS-CoV-2 detection. The test that will be available across the country through the network of Apollo Hospitals, will focus on increasing the manufacturing and commercialisation of the tests jointly, a release issued on Thursday (December 14) said.
Also Read:Scientists Develop Smartphone-Read Saliva Testing Method For COVID-19
As per the release, the DArRT-PCR test helps in rapid, safer and more cost-effective SARS-COV-2 testing. The centres collecting samples can send dry nasal or oropharyngeal swabs to testing centres without any requirement for imported and costly Viral Transport Medium.
As people are getting back to their normal lives and businesses, it is important for us to ramp up our testing for the coronavirus. The virus will be here for some time, it seems, and those who test more frequently will be able to contain the impact of COVID-19 better. Cheaper, rapid, accurate and easy to use tests as these are the need of the hour. With Apollo and its vast network of hospitals and health services, we expect impacting many lives towards better health, said Dr Rakesh Mishra, Director, CSIR-CCMB.
“We are glad to collaborate with CSIR-CCMB in this path-breaking initiative of a more rapid, easy to use and accurate testing option and work to make it available nationwide. The Apollo Hospitals Group has always been at the forefront of cutting-edge medical technology and a pioneer in implementing the latest advances for the benefit of patients. Co-creating and commercialising an Indian solution in line with our prime minister’s vision of Atmanirbhar Bharat is an important landmark for Apollo Hospitals,” said Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group.
Also Read:Coronavirus Outbreak Explained: What Are Mild Symptoms Of COVID-19?
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the currentCOVID-19 pandemic, the need for WASH (Water,SanitationandHygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fightmalnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India wheretoiletsare used andopen defecation free (ODF)status achieved as part of the Swachh Bharat Abhiyan launched byPrime Minister Narendra Modiin 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues likeair pollution,waste management,plastic ban,manual scavengingand sanitation workers andmenstrual hygiene.